| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.004 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |